Skip to main content

Advertisement

Log in

Disseminated Infection due to Saksenaea vasiformis Secondary to Cutaneous Mucormycosis

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Mucormycosis is an uncommon opportunistic fungal infection caused by Zygomycetes. It usually affects immunocompromised, diabetic and trauma patients with infected wounds. We report a case of disseminated infection secondary to facial cutaneous mucormycosis caused by Saksenaea vasiformis in a diabetic patient who had a farming accident causing him severe head injury. The patient was treated with a combination of surgical debridement and antifungal therapy with liposomal amphotericin B, but he had a slow and fatal outcome. In cases of tissue necrosis following trauma involving wound contact with soil (i.e., potential fungal contamination), testing for the presence of Zygomycetes fungi such as S. vasiformis in both immunocompetent and immunocompromised patients is crucial. The reason is that this infection usually has a rapid progression and may be fatal if appropriate treatment is not administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S16–22.

    Article  CAS  PubMed  Google Scholar 

  2. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23.

    Article  PubMed  Google Scholar 

  3. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24:411–45.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Vega W, Orellana M, Zaror L, Gené J, Guarro J. Saksenaea vasiformis infections: case report and literature review. Mycopathologia. 2006;162:289–94.

    Article  PubMed  Google Scholar 

  6. Taj-Aldeen SJ, Falamarzi A, AlMuzrkchi A, Guarro J. Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis. Infection. 2012;40:703–7.

    Article  CAS  PubMed  Google Scholar 

  7. Holden DW. DNA mini prep method for Aspergillus fumigatus (and other filamentous fungi). In: Maresca B, Kobayashi GS, editors. Molecular biology of pathogenic fungi, a laboratory manual. New York, NY: Telos Press; 1994. p. 3–4.

    Google Scholar 

  8. Saksena SB. A new genus of the Mucorales. Mycologia. 1953;45:426–36.

    Google Scholar 

  9. Alvarez E, Garcia-Hermoso D, Sutton DA, et al. Molecular phylogeny and proposal of two species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol. 2010;48:4410–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia. 1976;68:52–62.

    Article  CAS  PubMed  Google Scholar 

  11. Baradkar VP, Mathur M, Taklikar S, Rathi M, Kumar S. Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India. Indian J Med Microbiol. 2008;26:385–7.

    Article  CAS  PubMed  Google Scholar 

  12. Kompoti M, Michalia M, Kallitsi G, Giannopoulou P, Arabatzis M, Liapi G, Velegraki A, Trikka-Graphakos E, Clouva-Molyvdas PM. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses. 2011;54:599–601.

    Article  Google Scholar 

  13. García-Martínez J, López-Medrano F, Alhambra A, Del Palacio A. Rhinocerebral zygomycosis caused by Saksenaea vasiformis in a diabetic patient. Mycoses. 2008;51:549–53.

    Article  PubMed  Google Scholar 

  14. Gonis G, Starr M. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr Infect Dis J. 1997;16:714–6.

    Article  CAS  PubMed  Google Scholar 

  15. Baradkar VP, Kumar S. Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host. Indian J Dermatol. 2009;54:382–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Padhye AA, Ajello L. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol. 1988;26:1861–3.

    CAS  PubMed Central  PubMed  Google Scholar 

  17. Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32:1823–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Ayats J, Martín-Mazuelos E, Pemán J, Quindós G, Sánchez F, García-Rodríguez J, et al. Spanish society of clinical microbiology and infectious diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update. Enferm Infecc Microbiol Clin. 2011;29(39):e1–15.

    PubMed  Google Scholar 

  19. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54(Suppl 1):S55–60.

    Article  PubMed  Google Scholar 

  20. Lanternier F, Lortholary O. Liposomal amphotericin B: what is its role in 2008? Clin Microbiol Infect. 2008;14(Suppl 4):S71–83.

    Article  Google Scholar 

  21. Rammaert Blandine, Lanternier Fanny, Zahar Jean-Ralph, et al. Healthcare-associated mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S44–54.

    Article  PubMed  Google Scholar 

  22. Domínguez MdelC, Sánchez J, Carmona E, Vergara-López S. Elderly patient with rapidly progressive skin lesions. Enferm Infecc Microbiol Clin. 2012;30:43–5.

    Article  Google Scholar 

  23. Spellberg B, Ibrahim A, Roilides E, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012;54(Suppl 1):S73–8.

    Article  CAS  PubMed  Google Scholar 

  24. Gómez-López A, Cuenca-Estrella M, Monzón A, Rodríguez-Tudela JL. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J Antimicrob Chemother. 2001;48:919–21.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the National Center of Microbiology of Majadahonda (Madrid, Spain) for their technical support.

Conflict of interest

The authors certify no conflicts of interest in relation to this article exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cristina Gómez-Camarasa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gómez-Camarasa, C., Rojo-Martín, M.D., Miranda-Casas, C. et al. Disseminated Infection due to Saksenaea vasiformis Secondary to Cutaneous Mucormycosis. Mycopathologia 177, 97–101 (2014). https://doi.org/10.1007/s11046-013-9715-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-013-9715-3

Keywords

Navigation